Pharmacological modulation of AMPA receptors rescues specific impairments in social behavior associated with the A350V Iqsec2 mutation
Open Access
- 22 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 11 (1), 1-11
- https://doi.org/10.1038/s41398-021-01347-1
Abstract
In this study we tested the hypothesis that pharmacological modulation of glutamatergic neurotransmission could rescue behavioral deficits exhibited by mice carrying a specific mutation in the Iqsec2 gene. The IQSEC2 protein plays a key role in glutamatergic synapses and mutations in the IQSEC2 gene are a frequent cause of neurodevelopmental disorders. We have recently reported on the molecular pathophysiology of one such mutation A350V and demonstrated that this mutation downregulates AMPA type glutamatergic receptors (AMPAR) in A350V mice. Here we sought to identify behavioral deficits in A350V mice and hypothesized that we could rescue these deficits by PF-4778574, a positive AMPAR modulator. Using a battery of social behavioral tasks, we found that A350V Iqsec2 mice exhibit specific deficits in sex preference and emotional state preference behaviors as well as in vocalizations when encountering a female mouse. The social discrimination deficits, but not the impaired vocalization, were rescued with a single dose of PF-4778574. We conclude that social behavior deficits associated with the A350V Iqsec2 mutation may be rescued by enhancing AMPAR mediated synaptic transmission.Funding Information
- Israel Science Foundation (1350/12, 1361/17)
- Ministry of Science, Technology and Space (3-12068)
- Human Frontier Science Program (RGP0019/2015)
This publication has 45 references indexed in Scilit:
- 16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social InteractionsAutism Research, 2015
- AMPA receptor potentiators: from drug design to cognitive enhancementCurrent Opinion in Pharmacology, 2015
- AMPA Receptor antagonist NBQX attenuates later‐life epileptic seizures and autistic‐like social deficits following neonatal seizuresEpilepsia, 2013
- Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574The Journal of pharmacology and experimental therapeutics, 2013
- Arf6-GEF BRAG1 Regulates JNK-Mediated Synaptic Removal of GluA1-Containing AMPA Receptors: A New Mechanism for Nonsyndromic X-Linked Mental DisorderJournal of Neuroscience, 2012
- Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor functionNature, 2012
- Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disabilitySmall GTPases, 2010
- Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disabilityNature Genetics, 2010
- Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Cell‐specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubersAnnals of Neurology, 2008